Phathom Pharmaceuticals (PHAT) Return on Assets (2019 - 2026)

Phathom Pharmaceuticals (PHAT) has 8 years of Return on Assets data on file, last reported at 0.01% in Q1 2026.

• On a quarterly basis, Return on Assets changed 0.0% year-over-year to 0.01% in Q1 2026; TTM through Mar 2026 was 0.01%, a 0.0% change from a year earlier, with the FY2025 full-year figure at 0.01%, up 1.0% from the prior year.
• Return on Assets for Q1 2026 stood at 0.01%, up from 0.01% in the prior quarter.
• Over the last five years, Return on Assets for PHAT reached as high as 0.01% in Q4 2023 and fell as low as 0.01% in Q2 2025.
• Historically, Return on Assets has averaged 0.01% across 5 years, with a median of 0.01% in 2025.
• Across the five-year window, Return on Assets fell 1 bps in 2022 and grew 1 bps in 2024, its largest moves.
• Year by year, Return on Assets stood at 0.01% in 2022, then soared by 33 bps to 0.01% in 2023, then tumbled by 37 bps to 0.01% in 2024, then decreased by 6 bps to 0.01% in 2025, then rose by 28 bps to 0.01% in 2026.
• Per Business Quant data, the three most recent Return on Assets figures were 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.